Affinity Chromatography.

19,714 views 24 slides May 21, 2021
Slide 1
Slide 1 of 24
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24

About This Presentation

In this slide contains detail about Affinity Chromatography.
Presented by: T.Jayasree. ( Department of pharmaceutical analysis).
RIPER,anantpur.


Slide Content

1 A Seminar as a part of curricular requirement for I year M .Pharm I Semester Presented by Ms . T.Jayasree ( 20L81S0709) Pharmaceutical analysis Under the guidance/Mentorship of Dr .P.Ramalingam., M.Pharm, Ph.D Director- R&D Division, Professor of pharmaceutical analysis and medicinal chemistry President - IPA local branch - Anantapuramu Affinity Chromatography

2 Introduction Principle Stationary Phase Mobile phase Affinity Media Chromatographic Media Immobilized ligands Attachment of ligands to the matrix Procedure Batch and column setup Applications Contents

3 Affinity chromatography was discovered by Pedro Cuatrecasas and Meir Wilcheck. Affinity Chromatography is essentially a sample purification technique , used primarily for biological molecules such as proteins. It is a method of separating a mixture of proteins or nucleic acids by specific interactions of those molecules with a component known as ligands , which is immobilized on a support. Introduction

4 If a solution of say , a mixture of proteins is passed over the column , one of the proteins bind to the ligand on the basis of specifity and high affinity. Ex:- Enzymes for their substrate Antibodies for their antigens

5 The Principle is based on highly specific biological interactions between two molecules such as interactions between enzyme and substrate, receptor and ligand , or antibody and antigen. These interactions which are typically reversible are used for purification by placing one of the interacting molecules referred to as affinity ligand onto a solid matrix to create a stationary phase while a target molecule is in the mobile phase. Principle

6

7 It is an insoluble solid matrix (porous or non-porous) covalently bonded to an immobilized ligand separated by a spacer arm Solid matrix (support material): Natural : cellulose,agarose,dextrose Synthetic : polymethacrylate ,polystyrene, polyacrylamide etc. Inorganic : porous silica ,glass etc. Stationary phase

8 Spacer arm: Creates spaces between matrix and ligand Provide better interaction between the ligand and target molecule by overcoming steric hindrance Affinity ligand: It is a molecule that binds to specific target molecule reversibly .

9 Mobile phase – buffer solution Binding buffer ( equilibrium and sample application): Optimize the conditions to ensure the binding of target molecules to the specific ligand . Elution buffer (Elution) – Conditions are reversed to weaken the interaction between the target molecules and ligand to elute the target molecules. Wash buff er (Washing) - Conditions suitable to wash the unbound molecule without eluting the target molecules. Mobile phase

10 Amino acids – serum proteins, proteins, peptides, enzymes as well as rRNA dsDNA. Avdin – Biotin – purification process of avidin , biotin and their derivatives . Carbohydrates – glycoprotein's carbohydrate containing substance lectins . Dye ligands : biological substrates and proteins . Glutathione – GST tagged recombinant proteins . Heparin – plasma coagulation proteins , nucleic acid enzymes and lipases Affinity Media

11 A matrix in its use here is a substance, usually in bead form to which a specific ligand is covalently bound. In order for the matrix to be effective it must have certain characters: It must be insoluble in solvents and buffers employed in the process. It must be chemically and Mechanically stable. Chromatographic Media

12 It must be easily coupled to a Ligand or Spacer arm onto which the ligand can be attached. It must exhibit good flow properties and have a relatively large surface area for attachment.

13 The Ligand can be selected only after the nature of the macromolecule to be isolated is known . When a hormone receptor protein is to be purified by affinity chromatography, the hormone itself is an ideal candidate for the ligand . For antibody isolation, an antigen or hapten may be used as a ligand. If an enzyme is to be purified, a substrate analog , inhibitor, cofactor , or effectors may be used as an immobilized ligand . Immobilized Ligand

14 Several procedures have been developed for the covalent attachment of the ligand to the stationary phase. All procedures for gel modifications proceed in two separate chemical steps. Activation of the functional groups on the matrix . Joining of the ligand to the functional groups on the matrix. Attachment of Ligand to Matrix

15 Affinity medium is equilibrated in binding buffer. Sample is applied under conditions that favor specific binding of the target molecule(s) to a complementatary binding substance (the ligand),Target substances bind specifically, but reversibily,to the ligand and unbound material washes through the column. Target protein is recovered by changing conditions to favor elution of the bound molecules, Elution is performed specifically, using a competitive ligand, or non-specifically ,by changing the pH,ionic strength or polarity ,Target protein is collected in a purified, concentrated form. Procedure

16 4. Affinity medium is re-equilibrated with binding buffer.

17 Binding to the solid phase may be achieved by column chromatography whereby the solid medium is packed onto a column , the intial mixture run through the column to allow setting , a wash buffer run through the column and the elution buffer subsequently applied to the column and collected. BATCH AND COLUMN SETUP

18 These steps are usually done at ambient pressure . Alternatively, binding may be achieved using a batch treatment, for example, by adding the intial mixture to the solid phase in a vessel, mixing, seperatingthe solid phase, removing the liquid phase,washing, re-centrifuging, adding the elution buffer, re-centrifuging and removing the eluate.

19 Sometimes a hybrid method is employed such that the binding is done by the batch method, such that the binding is done by the batch method, but the solid phase with the target molecule bound is packed onto a column and washing and elution are done on the column. A third method, expanded bed adsorption,which combines the advantages of the two methods mentioned above,has also been developed.

20 The solid phase particles are placed in a column where liquid phase is pumped in form the bottom and exits at the top. The gravity of the particles ensure that the solid phase does not exit the column with the liquid phase . Affinity columns can be eluted by changing salt concentrations,pH,pl,charge and ionic strength directly or through a gradient to resolve the particles of interest .

21 Column setup Batch setup Steps

22 It is used for isolation and purification of all biological macromolecules. It is used to purify nucleic acid , antibodies , and enzymes . To notice which biological compounds bind to a particular substance . To reduce an amount of substance in a mixture. Used in Genetic Engineering-nucleic acid purification. Production of Vaccines-antibody purification from blood serum. And Basic Metabolic Research-protein or enzyme purification from cell free extracts. Applications

23 Parikh I, Cuatrecasas P. Affinity chromatography, principles and applications. InMethods of Protein Separation 1975 (pp. 255-276). Springer, Boston, MA. Boyer R. Modern experimental biochemistry. Pearson Education India; 2000. Sawhney SK, Singh R, editors. Introductory practical biochemistry. Alpha Science Int'l Ltd.; 2000. Noctor TA, Wainer IW, Hage DS. Allosteric and competitive displacement of drugs from human serum albumin by octanoic acid, as revealed by high-performance liquid affinity chromatography, on a human serum albumin-based stationary phase. Journal of Chromatography B: Biomedical Sciences and Applications. 1992 Jun 10;577(2):305-15. References
Tags